- Home
- Products
ERIVEDGE (Vismodegib Tablet)
ERIVEDGE (Vismodegib Tablet)
- Medicine Name: ERIVEDGE
- Generic Name: Vismodegib
- Dosage Form & Strength: 150 mg Capsule
- Form: Oral
- Manufactured By: Patheon, Inc.
- FDA Approval: Yes (Approved on January 30, 2012)
ERIVEDGE (Vismodegib) is a hedgehog pathway inhibitor indicated for the treatment of:
- Adults with metastatic basal cell carcinoma (mBCC)
- Adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or who are not candidates for surgery or radiation
This targeted therapy blocks the hedgehog signaling pathway, which plays a key role in the development of basal cell carcinoma.
Embryo-Fetal Toxicity: ERIVEDGE can cause severe birth defects or fetal death. Contraindicated during pregnancy. Use effective contraception during and after treatment.
Blood Donation Restriction: Do not donate blood or blood products during treatment and for at least 7 months after the final dose.
Muscle Spasms and Weight Loss: Frequently reported. Monitor patient’s muscle condition and nutrition.
Menstrual Irregularities: Amenorrhea has been observed in female patients of reproductive potential.
Use with Caution in Liver and Renal Impairment: Limited data available—monitor accordingly.
Documents Required to Import ERIVEDGE into India:
- Valid oncologist’s prescription
- Diagnostic reports confirming the indication
- Government-issued photo ID of the patient
- Import permit, if required under applicable Indian law
Availability:
ERIVEDGE is not commercially sold in Indian pharmacies. It can be legally accessed under the Named Patient Import Program with appropriate documentation. Delivery available in Mumbai, Delhi, Chennai, Hyderabad, Bangalore, Pune, Ahmedabad, and other cities.
Global Rare Meds sources ERIVEDGE (Vismodegib 150 mg) from certified pharmaceutical suppliers across the USA, Europe, Canada, and Australia.
- Prescriptions are verified and dispensed by licensed pharmacists
- Medicines are shipped from our fulfillment center in Ambernath, Thane District
- Safe packaging and cold-chain logistics used where required
We ensure product authenticity, compliance, and global delivery in a timely and transparent manner.
What is the generic name of ERIVEDGE?
Vismodegib
Who manufactures ERIVEDGE?
Patheon, Inc.
Is ERIVEDGE approved by the FDA?
Yes, it was approved by the U.S. FDA on January 30, 2012.
What is ERIVEDGE used for?
ERIVEDGE is used to treat advanced or metastatic basal cell carcinoma that is not suitable for surgery or radiation.
What is the dosage form and strength?
Oral capsule – 150 mg
Is ERIVEDGE available in India?
Not through retail pharmacies. It can be accessed via Named Patient Supply for eligible patients.
Are generic versions of ERIVEDGE available?
As of now, no approved generics or biosimilars are available for Vismodegib.
What are the known side effects of ERIVEDGE?
Muscle spasms, hair loss, weight loss, altered taste, fatigue, nausea, decreased appetite, and amenorrhea.
How can I order ERIVEDGE in India?
Contact Global Rare Meds to begin the documentation and import process.
What is the price of ERIVEDGE in India?
For current pricing and availability, contact:
Phone: +91-99675 15602
WhatsApp: +91-99675 15602
Email: info@globalraremeds.com
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
